Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
02/2011
02/23/2011EP2287147A2 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
02/23/2011EP2285764A2 Monoetherified diols of diamondoids
02/23/2011EP2285760A2 Cure accelerators for anaerobic curable compositions
02/23/2011EP1840218B1 Process for production of optically active (S)- or (R)-beta-amino acids and optically active (R)- or (S)-beta -amino acid esters, and optically active (S)- or (R)-2-alkoxyethyl esters of beta-amino acids.
02/23/2011CN101979378A Method for synthesizing chiral gamma-lactam compounds
02/22/2011USRE42164 Hepatitis C inhibitor tri-peptides
02/22/2011US7893297 Amorphous sodium 4-[4-chloro-2-hydroxybenzoyl)amino]butanoate
02/22/2011US7893296 Method for producing an optically active β-amino acid
02/22/2011US7893292 Merocyanine derivatives for cosmetic use
02/22/2011US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
02/22/2011US7892748 Reagent for detecting an analyte
02/22/2011CA2571816C Absorbent for separation of carbon dioxide
02/22/2011CA2540678C Pharmaceutical compositions for prevention of overdose or abuse
02/22/2011CA2350882C Transfection reagents
02/17/2011WO2011019882A1 Nanostructure-beta-blocker conjugates
02/17/2011WO2010123599A9 Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus
02/17/2011WO2010118291A3 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
02/17/2011US20110040094 1,3,4-trisubstituted benzenes
02/17/2011US20110039933 S1p-1 receptor agonists
02/17/2011US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039812 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use
02/17/2011US20110039714 Probes, Systems, and Methods for Drug Discovery
02/16/2011EP2284174A1 Intermediates for the preparation of benzoxazine derivatives and process for their preparation
02/16/2011EP2282982A1 Novel [f-18]-labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
02/16/2011EP2282981A1 {f-19} -labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
02/16/2011CN101977889A Method for producing fluorine-containing acylacetic acid derivative, method for producing fluorine-containing pyrazolecarboxylic acid ester derivative, and method for producing fluorine-containing pyrazolecarboxylic acid derivative
02/16/2011CN101973941A Method for preparing 4-hydroxyphenyl hydantoin
02/16/2011CN101973902A Synthesis method of para aminobenzoic acid
02/16/2011CN101973901A Glutamic acid continuous isoelectric crystallization method
02/16/2011CN101973900A Production process for deodorizing and decolorizing fenugreek seed extract
02/16/2011CN101973899A Novel production process of nanometer calcium amino acid chelate with high efficiency
02/15/2011US7888532 Two-photon probe for real-time monitoring of intracellular magnesium ions, method for preparing the two-photon probe and method for real-time monitoring of intracellular magnesium ions using the two-photon probe
02/15/2011US7888531 Nateglinide crystals
02/15/2011US7888526 Acid addition salts of 5-aminolevulinic acid or its derivatives
02/15/2011US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting
02/15/2011CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein
02/15/2011CA2456411C Stilbene derivatives and their use for binding and imaging amyloid plaques
02/15/2011CA2450213C Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same
02/10/2011US20110034726 Process Of Preparation Of Optically Active Alpha Aminoacetals
02/10/2011US20110034553 Novel conjugates for treating neurodegenerative diseases and disorders
02/10/2011US20110034552 Long-chain oxyaminopolyol based gelator and gel
02/10/2011US20110034528 Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof
02/10/2011US20110033633 Method of making ligand functionalized substrates
02/10/2011US20110033390 Mr imaging agent or medium compressing hyperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used
02/10/2011US20110033362 Process for Producing Hydrocyanic Acid
02/09/2011EP2281801A1 Process for obtaining 3,3-diphenylpropylamines
02/09/2011EP2280931A1 Process for converting tryptophan into kynurenine
02/09/2011EP2280930A1 A novel and efficient method for the synthesis of an amino acid
02/09/2011EP2280915A1 Novel ýf-18¨-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
02/09/2011CN101967126A Chiral leucine ion liquid
02/09/2011CN101967106A Method for treating L-p-hydroxyphenylglycine desalting mother liquor by adopting bipolar membrane electrodialysis technology
02/09/2011CN101967076A Preparation method of nitrogen dimethylated derivative of amino acid
02/09/2011CN101966455A Method for preparing high-selectivity palladium-carbon catalyst by attachment and precipitation process
02/09/2011CN101151256B Process for production of dibenzoxepin derivative
02/08/2011US7884234 N-[4-(tert-butyl)benzyl]-N-[4 -(trifluoromethoxy)biphenyl-3-yl]oxamic Acid; Inhibitors of plasminogen activator inhibitor-1 (PAI-1); thrombogenesis, fibrogenesis, accumulation of visceral fat, cell proliferation, angiogenesis
02/08/2011US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
02/08/2011CA2562951C Indene derivatives and process for the preparation thereof
02/08/2011CA2484450C Ligands that are inhibitors of the rar receptors
02/03/2011US20110028753 Stabilized Compounds Having Secondary Structure Motifs
02/03/2011US20110028725 Preparation and Use of Alkylating Agents
02/03/2011US20110028463 Amide compounds
02/03/2011US20110027274 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
02/03/2011US20110027179 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
02/03/2011CA2769633A1 Crystallization method and bioavailability
02/02/2011EP2279997A1 Fluorinated cyclopropane analogs of glutamic acid
02/02/2011CN1972904B Preparation of pregabalin and related compounds
02/02/2011CN101213193B Mono-lysine salts of azole compounds
02/02/2011CN101195570B Salt amino acid of ferulic acid
02/01/2011US7879907 Peroxisome Proliferator-Activated Receptor (PPAR) activators such as 3-{4-[3-(4-benzyloxy-3-methoxyphenyl)propyl]-3-butoxyphenyl}propanoic acid, used in dermatology, cosmetics, cardiovascular diseases, immunology and/or lipid metabolism
02/01/2011US7879827 such as 5-amino-2-(2-Acetylamino-3-mercapto-propionyloxy)-benzoic acid, useful for the treatment of gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome, and for the prevention/treatment of colon cancer
01/2011
01/27/2011WO2011009947A1 Fluorinated cyclopropane analogs of glutamic acid
01/27/2011WO2010136036A3 Calcium-sensing receptor-active compounds
01/27/2011US20110022326 Quantitation Method Using Isotope Labeled Internal Standard Substance, Analysis System for Executing the Quantitation Method, and Program for the Analysis
01/27/2011US20110021815 Halogenated analogues of anti-fibrotic agents
01/27/2011US20110021814 Method for reducing aminoisophthalic acid bisamide related impurities in preparation of non-ionic x-ray contrast agents
01/27/2011US20110021762 Method of forming oseltamivir and derivatives thereof
01/27/2011US20110021761 Segmented Polymers and Their Conjugates
01/27/2011US20110021628 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
01/27/2011US20110021482 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
01/27/2011US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof
01/27/2011US20110020251 Ultraviolet-Absorbing Compounds
01/27/2011US20110018866 Structure of the farnesoid x receptor ligand binding domain and methods of use therefor
01/27/2011CA2769053A1 Fluorinated cyclopropane analogs of glutamic acid
01/26/2011EP2277870A1 Substituted benzoxa(thia)zoles
01/26/2011EP2276724A2 Novel synthesis and applications of amino carboxylates
01/26/2011CN101959848A Cyclohexanedimethanamine by direct amination of cyclohexanedimethanol
01/26/2011CN101959847A Method for the production of aminodicarboxylic acid-N,N-diacetic acids
01/26/2011CN101955547A Method for comprehensively extracting changium smyrnioide polysaccharides and amino acid
01/26/2011CN101955470A Potentiators of glutamate receptors
01/26/2011CN101955438A Method for preparing L-(+)-alpha-phenylglycine
01/26/2011CN101955437A Glyphosate and glycine co-production technology by utilizing IDA method
01/26/2011CN101954280A Copper and iron-series catalyst used for low temperature oxydehydrogenation of alkylol amine for preparing amino carboxylate
01/26/2011CN101337949B Method for synthesizing beta-amido carboxylic acid ester
01/26/2011CN101077875B Boronic ester and acid compounds, synthesis and uses
01/25/2011CA2454532C Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
01/25/2011CA2405853C Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
01/20/2011WO2011006763A1 A process for the preparation of fe(iii) chelates of n,n'-di(2-hydroxybenzyl)-ethylenediamine-n,n'-diacetic acid and its derivatives
01/20/2011WO2011006621A1 Radiolabelling method using cycloalkyl groups
01/20/2011WO2010136035A3 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 215